Steven Demeester
Thoracic Surgery (Cardiothoracic Vascular Surgery) · Portland, ORNPI 1609807973
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (52.6%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Davol Inc. accounts for 94.0% of it on its own, with 21 other manufacturers making up the rest. Reporting peaked in 2019 at $218,452 and has fallen 95.2% since, to $10,537 in 2025. Among thoracic surgery (cardiothoracic vascular surgery) clinicians in OR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 437 payments — averaging $1295.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Davol Inc.$532K
- TELA Bio, Inc.$11K
- C. R. Bard, Inc. & Subsidiaries$9K
- Covidien LP$6K
- Boston Scientific$3K
- Mauna Kea Technologies, Inc.$2K
- plus $4K from 16 others
What the payments were for
- Consulting fees$215,09538%
- Speaking & faculty fees$297,68353%
- Travel & lodging$38,9357%
- Food & beverage$14,6193%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Davol Inc. | 308 | $532,159 |
| TELA Bio, Inc. | 24 | $10,656 |
| C. R. Bard, Inc. & Subsidiaries | 8 | $8,820 |
| Covidien LP | 6 | $5,520 |
| Boston Scientific | 28 | $3,498 |
| Mauna Kea Technologies, Inc. | 5 | $1,616 |
| W. L. Gore & Associates, Inc. | 17 | $1,230 |
| Phathom Pharmaceuticals, Inc. | 5 | $453 |
| Medtronic | 5 | $452 |
| Intuitive Surgical | 5 | $321 |
| Pinnacle Biologics, Inc | 4 | $304 |
| Endogastric Solutions, Inc | 4 | $293 |
| Johnson & Johnson | 5 | $292 |
| Enterra Medical, Inc. | 1 | $176 |
| Pentax Of America, Inc. | 3 | $165 |
| Ambu Inc. | 1 | $115 |
| Lucid Diagnostics Inc. | 2 | $109 |
| Atricure, Inc. | 1 | $60 |
| Bard Access Systems, Inc. | 2 | $43 |
| Olympus America Inc. | 1 | $18 |
| LSI Solutions Inc | 1 | $17 |
| Coopersurgical, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PHASIX$100,429
- Phasix Mesh$14,375
- OviTex Reinforced Bioscaffold With Permanent Polymer (OviTex)$10,231
- TA$3,400
- LigaSure$1,902
- GORE ENFORM Preperitoneal Biomaterial$843
- GENERAL - THERAPIES$550
- VOQUEZNA$407
- SPYGLASS$155
- EsoFlip$149
- ESOPHYX$146
- Bravo$124
- Resolution 360 Clip$124
- Signia$120
- C2 Cryoballoon$118
- Photofrin$116
- WallFlex Duodenal$114
- EXALT BX 2$111
How this compares
$566,331 in reported general payments places this provider in the 95th percentile of 52 thoracic surgery (cardiothoracic vascular surgery) providers in Oregon.
See all thoracic surgery (cardiothoracic vascular surgery) providers in Oregon →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Omeprazole | 14 | $194 |
Paid to pharmacies, not to this prescriber.
Other thoracic surgery (cardiothoracic vascular surgery) in Portland
- Howard SongPortland$64K
- Castigliano BhamidipatiPortland$52K
- Areo SaffarzadehPortland$51K
- Jonathan DanielPortland$49K
- Robert DubosePortland$45K
- Brandon TieuPortland$39K
- Kevin KoomalsinghPortland$34K
- Jeffrey BoskindPortland$30K
- Aubyn MarathPortland$29K
- Gurion LantzPortland$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.